If you have ever caught yourself doom scrolling on Instagram or Facebook for hours on end and felt bad, don’t; the technology is working exactly how it was intended to. Everything from the length and style of the Reels to the algorithms’ encyclopedic knowledge of your likes and dislikes is designed to keep you on […]

The Iran War, tariffs and the demand-driven AI-investment boon could add up to create inflationary conditions where Federal Reserve policymakers would need to consider interest-rate hikes later this year. But not just yet.  According to the minutes of the June Federal Open Market Committee meeting, policymakers at the central bank were concerned about high inflation

T-Mobile is facing backlash for revoking a privilege that customers used when chatting with customer support representatives in the T-Life app.  The change comes as the carrier has been making customers increasingly reliant on the app to handle account changes in recent months. For example, in October, T-Mobile began requiring customers to use its T-Life

International Business Machines (IBM) has spent years trying to convince investors that it deserves a new label. For Wall Street, IBM long looked like a legacy hardware and consulting company with limited upside. As IBM shifts deeper into higher-margin software, AI infrastructure, and free cash flow, it becomes increasingly difficult to justify that perspective. Bank

Tesla’s (TSLA) fresh bull case lands at a strange moment for the stock. Investors were anxiously waiting for a demand reset after concerns of some major EV competition, sluggish margins, and lackluster growth.  However, in a surprise turn of events, Tesla then beat Q2 delivery estimates by a wide margin, giving bulls a rare hard-data

Eli Lilly (LLY) keeps setting records, and Wall Street’s rating of its stock keeps increasing as well.  On Tuesday, one of JPMorgan’s most closely watched healthcare stock analysts, Chris Schott, who frequently covers Pfizer Inc. (PFE), Eli Lilly, and Teva Pharmaceutical Industries Ltd. (TEVA), gave investors something to pay attention to. He set a new

The housing market has been a bit lackluster in the first half of 2026. High mortgage rates and home prices have kept homebuyer demand down. As a result, sellers are hesitant to list their homes for fear of them staying on the market too long or being forced to sell at a lower price. This

As Americans look to secure their financial futures, they are smartly looking to maximize their wealth for retirement, capitalizing on every available tax-advantaged account to build a robust nest egg. For decades, older workers have relied on special provisions to accelerate their savings during their peak earning years. Financial industry giants Fidelity Investments and Charles

Cathie Wood, head of Ark Investment Management, is known for buying her favorite tech stocks during market pullbacks.  That’s exactly what she just did, adding shares of an AI stock after a sharp selloff. In 2025, the flagship Ark Innovation ETF gained 35.49%, far outpacing the S&P 500’s return of 17.88% in the same period.

It’s been about five years since the U.S. Food and Drug Administration approved Wegovy for chronic weight management, but semaglutide, the active ingredient in Ozempic and similar drugs, goes back much further. Semaglutide was first synthesized in 2008 after scientists found that saliva extracted from Gila monsters contained a peptide that stimulated insulin release, similar